In breast cancer, PRMT6 catalyzes asymmetric dimethylation of STAT3 at R729, which enhances its membrane localization, interaction with JAK2, and phosphorylation at Y705, thereby promoting metastatic potential [408]. Here, PRMT6 is linked to breast carcinoma.